ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1197

Genetic Profiling of Idiopathic Inflammatory Myopathies in Indian Patients Reveals Genotype-Phenotype Correlation

Bandana Jassal1, Aishwarya Dhall1, Mohammed Faruq2, Danveer Bhadu1, Uma Kumar1 and Mehar Chand Sharma1, 1All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi, India, 2Institute of Genomics and Integrative Biology, New Delhi, Delhi, India

Meeting: ACR Convergence 2025

Keywords: Autoantibody(ies), autoimmune diseases, genetics, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1191–1220) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are rare autoimmune muscle disorders with complex genetic underpinnings. Most genetic studies have focused on limited populations. This study explores genetic risk factors in Indian IIM patients, integrating clinical, serological, and histopathological features to enhance understanding of its pathogenesis.

Methods: Genomic DNA was isolated from EDTA blood and libraries were prepared using the SureSelect XT HS2 protocol and sequenced on the Illumina NextSeq 2000 (2×150 bp). Variants were prioritized based on quality, frequency, predicted impact, and pathway relevance then selected variants were validated by Sanger sequencing using custom-designed primers and standard PCR. Frequently mutated genes were assessed for phenotype associations.

Results: A total of 91 prioritized variants were identified across 86 IIM cases, with mutations present in 68.6% (59/86). Of these, 4.4% were classified as pathogenic, 14.3% as likely pathogenic, and 81.3% as variants of uncertain significance (VUS). Most were nonsynonymous SNVs (80.2%), followed by frameshift deletions (5.5%), stopgain mutations (4.4%), and others. Notably, 25.3% were novel variants. Seventeen genes harbored ≥2 variants or at least one pathogenic/likely pathogenic variant, with five genes (CFTR, COL1A1, HBB, LRP5, and WDFY4) meeting both criteria for further evaluation. Among these, LRP5 carried five nonsynonymous SNVs across IIM subgroups. Domain mapping revealed key mutations within or adjacent to EGF-like and LDL-receptor domains (Figure 1). LRP5 mutations were significantly associated with proximal lower limb weakness (p=0.0372), anti-Ro52 (p=0.0369), and anti-TIF1γ autoantibodies (p=0.0156) (Table 1), suggesting a potential genotype-phenotype correlation.

Conclusion: This study identifies key genetic variants in Indian IIM patients, highlighting LRP5 as a potential marker linked to distinct clinical and serological features, advancing understanding of IIM pathogenesis.

Supporting image 1Figure 1. Mapping of LRP5 variants identified in the IIM Cohort

Supporting image 2Table 1. Comparison of characteristics of IIM Patients With and Without LRP5 Variants: This table presents a univariate comparison between idiopathic inflammatory myopathy (IIM) patients carrying prioritized LRP5 variants (n = 5) and those without such variants (n = 81). Clinical, histopathological, serological, and diagnostic variables are shown as counts with corresponding percentages. Statistical significance was assessed using Fisher’s exact test. Results are expressed as p-values with corresponding odds ratios (OR) and 95% confidence intervals (CI) in parentheses.


Disclosures: B. Jassal: None; A. Dhall: None; M. Faruq: None; D. Bhadu: None; U. Kumar: None; M. Sharma: None.

To cite this abstract in AMA style:

Jassal B, Dhall A, Faruq M, Bhadu D, Kumar U, Sharma M. Genetic Profiling of Idiopathic Inflammatory Myopathies in Indian Patients Reveals Genotype-Phenotype Correlation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/genetic-profiling-of-idiopathic-inflammatory-myopathies-in-indian-patients-reveals-genotype-phenotype-correlation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-profiling-of-idiopathic-inflammatory-myopathies-in-indian-patients-reveals-genotype-phenotype-correlation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology